PD-L1 Expressions in Non-small Cell Lung Cancer and its Correlation with Imaging Findings

被引：0
|
作者：
Shigeta, N. [1 ]
Adachi, H. [1 ]
Ito, H. [1 ]
Isaka, T. [1 ]
Murakami, K. [1 ]
Miura, J. [1 ]
Kikunishi, N. [1 ]
Saito, H. [1 ]
Yokose, T. [1 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
non-small cell lung cancer; PD-L1; imaging features;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.02-03
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [1] PD-L1 Expression and its Correlation with Tumor TNM Stage in Patients with Non-Small Cell Lung Cancer
    Jang, T.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S532 - S532
  • [2] Durvalumab for the treatment of PD-L1 non-small cell lung cancer
    Naito, Tomoyuki
    Shiraishi, Hideaki
    Fujiwara, Yutaka
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
  • [3] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [4] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [5] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [6] EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
    Yang, Huimin
    Zhu, Jinxiu
    Xiao, Rendong
    Liu, Yuhang
    Yu, Fanglin
    Cai, Lin
    Qiu, Minglian
    He, Fei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1001 - 1016
  • [7] EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
    Huimin Yang
    Jinxiu Zhu
    Rendong Xiao
    Yuhang Liu
    Fanglin Yu
    Lin Cai
    Minglian Qiu
    Fei He
    Cancer Immunology, Immunotherapy, 2022, 71 : 1001 - 1016
  • [8] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [9] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [10] Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
    Zhu, Lingling
    Lin, Jiewei
    Wang, Li
    Yan, Danli
    Zhou, Jie
    Li, Wen
    Pu, Dan
    Peng, Lei
    Zhou, Qinghua
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)
12345